CVE-2025-58403Reflected Cross-Site Scripting (XSS) in CGM CLININET
Updated under an hour ago ()
Does this affect you?
It affects CGM CLININET. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
CGM CLININET is vulnerable to Reflected Cross-Site Scripting (XSS) due to improper neutralization of user-supplied data. A remote unauthenticated attacker can craft a malicious URL containing JavaScript or HTML code, which is executed in the victim's browser when the URL is visited, allowing the attacker to steal session cookies and perform actions on behalf of the victim within the application. The vulnerability was confirmed to affect versions up to 2026.MS3 but later versions may also be vulnerable.
- CVSS
- 5.1 MEDIUM (v4.0, CNA)CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:A/VC:N/VI:N/VA:N/SC:L/SI:L/SA:N
- Weakness (CWE)
- CWE-79
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- CERT-PL
- NVD analysis
- Deferred
- Record last updated
- Oct 23, 2026
- First seen by InfoSec Signals
- Oct 23, 2026
Affected products
CGM CGM CLININET cgm:clininet (from the name) | through 2025.MS3 | CNA record |
References
- https://cert.pl/en/posts/2026/10/CVE-2025-30043/third-party-advisory
- https://www.cgm.com/pol_pl/products/szpital/cgm-clininet.htmlproduct
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.